Market cap
₹30 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-1 Cr
-
ROE
-1 %
-
ROCE
-1 %
-
Industry P/E
56.92
-
EV/EBITDA
-74.2
-
Debt to Equity
0
-
Book Value
₹1
-
EPS
₹-0
-
Face value
1
-
Shares outstanding
550,000,000
10 Years Aggregate
CFO
₹0.58 Cr
EBITDA
₹-2.34 Cr
Net Profit
₹-2.34 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Johnson Pharmacare
| -5.2 | -1.8 | -8.3 | -40.2 | 0.6 | 19.5 | -- |
|
BSE 500
| -5.7 | 0.0 | -5.5 | -1.1 | 12.4 | 11.9 | 12.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Johnson Pharmacare
| -48.7 | 62.9 | -1.4 | 18.8 | 144.5 | 9.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE 500
| 6.4 | 14.4 | 24.8 | 3.3 | 30.1 | 16.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Johnson Pharmacare
|
0.6 | 30.3 | 0.0 | -0.6 | -- | -0.8 | -- | 0.5 |
| 32.3 | 5,187.1 | 4,771.4 | 335.8 | 8.3 | 122.2 | 16.8 | 11.5 | |
| 90.8 | 577.0 | 0.0 | -0.2 | -- | -- | -- | 10.2 | |
| 163.5 | 966.5 | 4.6 | -8.7 | -141.1 | -0.2 | -- | 0.2 | |
| 64.8 | 9,720.0 | 3.0 | 180.7 | -3,294.4 | 5.5 | 36.9 | 5.0 | |
| 698.2 | 497.8 | 254.8 | 25.1 | -6.3 | 1.8 | 20.2 | 0.3 | |
| 429.0 | 775.2 | 108.2 | 13.6 | 20.3 | 20.2 | 56.9 | 7.1 | |
| 116.4 | 697.8 | 0.0 | 641.6 | -- | -- | 1.1 | -0.1 | |
| 29,900.0 | 919.0 | 66.1 | 2.8 | 1.8 | 9.6 | 8.4 | 0.7 | |
| 166.7 | 446.9 | 3,366.5 | 34.5 | 1.8 | 1.3 | 12.9 | 0.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Johnson Pharmacare
Sun And Shine Worldwide Limited does not have significant operations. Previously, it was involved in the purchase and sale of goods; and trading shares, mutual funds, and other investments. The company was formerly known as Robinson Worldwide Trade... Limited and changed its name to Sun And Shine Worldwide Limited in September 2011. Sun And Shine Worldwide Limited was incorporated in 1994 and is based in Ahmedabad, India. Read more
-
Incorporated
1994
-
Chairman
--
-
Managing Director
--
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Johnson Pharmacare
What is the current share price of Johnson Pharmacare Ltd Today?
The share price of Johnson Pharmacare Ltd is ₹0.55 (BSE) as of 13-May-2026 IST. Johnson Pharmacare Ltd has given a return of 0.61% in the last 3 years.
What is the current PB & PE ratio of Johnson Pharmacare Ltd?
Since, TTM earnings of Johnson Pharmacare Ltd is negative, P/E ratio is not available.
The P/B ratio of Johnson Pharmacare Ltd is 0.54 times as on 13-May-2026, a 43 discount to its peers’ median range of 0.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.91
|
|
2024
|
0.00
|
0.67
|
|
2023
|
0.00
|
0.42
|
|
2022
|
667.01
|
1.22
|
|
2021
|
1,272.73
|
0.24
|
What is the 52 Week High and Low of Johnson Pharmacare Ltd?
The 52-week high and low of Johnson Pharmacare Ltd are Rs 0.97 and Rs 0.47 as of 14-May-2026.
What is the market cap of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has a market capitalisation of ₹ 30 Cr as on 13-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Johnson Pharmacare Ltd?
Before investing in Johnson Pharmacare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.